FibroFix
Phase 1- Indications
- Knee cartilage repair
Company intelligence / Profile preview
FibroFix™ has demonstrated the ability to function like natural cartilage, supporting both immediate joint function and long-term regeneration of healthy tissue. The company’s products are designed to reduce symptoms, increase mobility, restore function, and prevent progression to osteoarthritis. Clinical development has been supported by major grants and Series A funding; specific trial results are not detailed in public sources but the company remains active with ongoing programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orthox.